M J van de Laar

1.2k total citations
25 papers, 931 citations indexed

About

M J van de Laar is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, M J van de Laar has authored 25 papers receiving a total of 931 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 13 papers in Microbiology and 8 papers in Infectious Diseases. Recurrent topics in M J van de Laar's work include Reproductive tract infections research (13 papers), HIV/AIDS Research and Interventions (8 papers) and HIV, Drug Use, Sexual Risk (7 papers). M J van de Laar is often cited by papers focused on Reproductive tract infections research (13 papers), HIV/AIDS Research and Interventions (8 papers) and HIV, Drug Use, Sexual Risk (7 papers). M J van de Laar collaborates with scholars based in Sweden, Netherlands and Denmark. M J van de Laar's co-authors include Merja Rantala, C A Ison, Magnus Unemo, Michelle Cole, Stephanie Chisholm, G Likatavicius, Y T van Duynhoven, Nerteley Quaye, Steen Hoffmann and Emma Johansson and has published in prestigious journals such as Journal of Antimicrobial Chemotherapy, Eurosurveillance and Sexually Transmitted Infections.

In The Last Decade

M J van de Laar

25 papers receiving 900 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M J van de Laar Sweden 20 518 422 236 234 228 25 931
Marita van de Laar Sweden 15 460 0.9× 542 1.3× 196 0.8× 357 1.5× 201 0.9× 23 979
William O. Harrison United States 14 230 0.4× 320 0.8× 107 0.5× 124 0.5× 191 0.8× 33 779
Irith De Baetselier Belgium 19 454 0.9× 552 1.3× 28 0.1× 265 1.1× 392 1.7× 88 985
Scott D. Holmberg United States 9 405 0.8× 88 0.2× 237 1.0× 84 0.4× 516 2.3× 10 978
M Samuel United States 9 630 1.2× 60 0.1× 92 0.4× 102 0.4× 523 2.3× 13 1.2k
Katy Sinka United Kingdom 18 737 1.4× 214 0.5× 37 0.2× 89 0.4× 502 2.2× 52 1.1k
Sandra W. Roush United States 7 518 1.0× 132 0.3× 68 0.3× 27 0.1× 263 1.2× 13 849
Catherine A. Chappell United States 14 270 0.5× 186 0.4× 181 0.8× 22 0.1× 223 1.0× 44 693
J. Bogaerts Rwanda 16 548 1.1× 182 0.4× 25 0.1× 104 0.4× 691 3.0× 51 1.2k
Reverianus Gabone Tanzania 11 96 0.2× 177 0.4× 36 0.2× 100 0.4× 272 1.2× 17 592

Countries citing papers authored by M J van de Laar

Since Specialization
Citations

This map shows the geographic impact of M J van de Laar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M J van de Laar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M J van de Laar more than expected).

Fields of papers citing papers by M J van de Laar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M J van de Laar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M J van de Laar. The network helps show where M J van de Laar may publish in the future.

Co-authorship network of co-authors of M J van de Laar

This figure shows the co-authorship network connecting the top 25 collaborators of M J van de Laar. A scholar is included among the top collaborators of M J van de Laar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M J van de Laar. M J van de Laar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Duffell, Erika & M J van de Laar. (2015). Survey of surveillance systems and select prevention activities for hepatitis B and C, European Union/European Economic Area, 2009. Eurosurveillance. 20(13). 17–24. 10 indexed citations
2.
Chisholm, Stephanie, Magnus Unemo, Nerteley Quaye, et al.. (2013). Molecular epidemiological typing within the European Gonococcal Antimicrobial Resistance Surveillance Programme reveals predominance of a multidrug-resistant clone. Eurosurveillance. 18(3). 103 indexed citations
3.
Cambiano, Valentina, Jemma L. O’Connor, Andrew Phillips, et al.. (2013). Antiretroviral therapy for prevention of HIV transmission: implications for Europe. Eurosurveillance. 18(48). 20647–20647. 18 indexed citations
4.
Pharris, Anastasia, Lucas Wiessing, O Sfetcu, et al.. (2011). Human immunodeficiency virus in injecting drug users in Europe following a reported increase of cases in Greece and Romania, 2011. Eurosurveillance. 16(48). 46 indexed citations
5.
Wiessing, Lucas, et al.. (2011). Trends in HIV and hepatitis C virus infections among injecting drug users in Europe, 2005 to 2010. Eurosurveillance. 16(48). 41 indexed citations
6.
Cole, Michelle, Magnus Unemo, Steen Hoffmann, et al.. (2011). The European gonococcal antimicrobial surveillance programme, 2009. Eurosurveillance. 16(42). 50 indexed citations
7.
Chisholm, Stephanie, Nerteley Quaye, Michelle Cole, et al.. (2010). An evaluation of gentamicin susceptibility of Neisseria gonorrhoeae isolates in Europe. Journal of Antimicrobial Chemotherapy. 66(3). 592–595. 57 indexed citations
8.
Savage, Emma, M J van de Laar, A. Gallay, et al.. (2009). Lymphogranuloma venereum in Europe, 2003-2008. Eurosurveillance. 14(48). 59 indexed citations
9.
Elford, Jonathan, et al.. (2009). HIV and STI behavioural surveillance among men who have sex with men in Europe. Eurosurveillance. 14(47). 33 indexed citations
10.
Rantala, Merja & M J van de Laar. (2008). Surveillance and epidemiology of hepatitis B and C in Europe – a review. Eurosurveillance. 13(21). 184 indexed citations
11.
Wiessing, Lucas, et al.. (2008). HIV among injecting drug users in Europe: increasing trends in the East. Eurosurveillance. 13(50). 20 indexed citations
12.
Laar, M J van de, Dominique L. Monnet, & M Herida. (2008). Multidrug-resistant methicillin-resistant Staphylococcus aureus (MRSA) strain in a men-who-have-sex-with-men (MSM) community in the United States: comment. Eurosurveillance. 13(3). 1–2. 27 indexed citations
13.
Laar, M J van de & C A Ison. (2007). Europe-wide investigation to assess the presence of new variant of Chlamydia trachomatis in Europe. Weekly releases (1997–2007). 12(6). E070208.4–E070208.4. 5 indexed citations
14.
Götz, Hannelore M, J M Ossewaarde, R F Nieuwenhuis, et al.. (2004). [A cluster of lymphogranuloma venereum among homosexual men in Rotterdam with implications for other countries in Western Europe].. PubMed. 148(9). 441–2. 27 indexed citations
15.
Duynhoven, Y T van, et al.. (1998). Patient referral outcome in gonorrhoea and chlamydial infections.. Sexually Transmitted Infections. 74(5). 323–330. 22 indexed citations
16.
Laar, M J van de, et al.. (1997). Surveillance of antibiotic resistance in Neisseria gonorrhoeae in The Netherlands, 1977-95.. Sexually Transmitted Infections. 73(6). 510–517. 26 indexed citations
17.
Duynhoven, Y T van, M J van de Laar, P H Rothbarth, et al.. (1997). Prevalence and risk factors for hepatitis B virus infections among visitors to an STD clinic.. Sexually Transmitted Infections. 73(6). 488–492. 16 indexed citations
18.
Laar, M J van de, Y T van Duynhoven, J S A Fennema, et al.. (1996). Differences in clinical manifestations of genital chlamydial infections related to serovars.. Sexually Transmitted Infections. 72(4). 261–265. 48 indexed citations
19.
Duynhoven, Y T van, M J van de Laar, J S A Fennema, G J van Doornum, & J A van den Hoek. (1995). Development and evaluation of screening strategies for Chlamydia trachomatis infections in an STD clinic.. Sexually Transmitted Infections. 71(6). 375–381. 19 indexed citations
20.
Laar, M J van de, et al.. (1990). Declining gonorrhoea rates in The Netherlands, 1976-88: consequences for the AIDS epidemic.. Sexually Transmitted Infections. 66(3). 148–155. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marita van de Laar Breakdown of academic impact, for papers by William O. Harrison Breakdown of academic impact, for papers by Irith De Baetselier Breakdown of academic impact, for papers by Scott D. Holmberg Breakdown of academic impact, for papers by M Samuel Breakdown of academic impact, for papers by Katy Sinka Breakdown of academic impact, for papers by Sandra W. Roush Breakdown of academic impact, for papers by Catherine A. Chappell Breakdown of academic impact, for papers by J. Bogaerts Breakdown of academic impact, for papers by Reverianus Gabone
Rankless by CCL
2026